Difference between revisions of "Chakrabarti 2022 Abstract Bioblast"
Tindle Lisa (talk | contribs) (Created page with "{{Abstract |title=left|100px|Chakrabarti Sasanka Ganguly U, Bir A, <u>Chakrabarti Sasanka</u> (2022) Cytotoxicity of mitochondrial Complex I inhibit...") |
|||
(7 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
[[File:Bioblast2022 banner.jpg|link=Bioblast_2022]] | |||
{{Abstract | {{Abstract | ||
|title=[[File:Chakrabarti S.JPG|left|100px|Chakrabarti Sasanka]] Ganguly U, Bir A, <u>Chakrabarti Sasanka</u> (2022) Cytotoxicity of mitochondrial Complex I inhibitor rotenone: a complex interplay of cell death pathways. Bioblast 2022: BEC Inaugural Conference.<br>[[ | |title=''Not presented'' [[File:Chakrabarti S.JPG|left|100px|Chakrabarti Sasanka]] Ganguly U, Bir A, <u>Chakrabarti Sasanka</u> (2022) Cytotoxicity of mitochondrial Complex I inhibitor rotenone: a complex interplay of cell death pathways. Bioblast 2022: BEC Inaugural Conference. In: https://doi.org/10.26124/bec:2022-0001 <br>[[Ganguly 2022 MitoFit|»''MitoFit Preprint''«]] | ||
|info=[https://wiki.oroboros.at/index.php/Bioblast_2022#Submitted_abstracts Bioblast 2022: BEC Inaugural Conference] | |info=[https://wiki.oroboros.at/index.php/Bioblast_2022#Submitted_abstracts Bioblast 2022: BEC Inaugural Conference] | ||
|authors=Ganguly Upasana, Bir Aritri, Chakrabarti Sasanka | |authors=Ganguly Upasana, Bir Aritri, Chakrabarti Sasanka | ||
|year=2022 | |year=2022 | ||
|event= | |||
|abstract=Ferroptosis has been identified as a type of regulated cell death triggered by a diverse set of agents with implications in various diseases like cancer and neurodegenerative diseases. Ferroptosis is iron-dependent and accompanied by an accumulation of reactive oxygen species (ROS) and lipid oxidation products, a depletion of reduced glutathione, mitochondrial morphological alterations and the rupture of cell membrane; the process is inhibited by specific antioxidants like ferrostatin-1 and liproxstatin-1 and by other general antioxidants like the iron-chelator deferoxamine, vitamin E and N-acetylcysteine. However, the mechanism of cell death in ferroptosis subsequent to the accumulation of ROS and lipid oxidation products is not clearly established. We show here that the classical mitochondrial Complex I inhibitor rotenone (0.5 µM) causes death of SH-SY5Y cells (a human neuroblastoma cell line) over a period of 48 h accompanied by mitochondrial membrane depolarization and intracellular ATP depletion. This is associated with an intracellular accumulation of ROS and the lipid oxidation product malondialdehyde or MDA and a decrease in reduced glutathione content. All these processes are inhibited very conspicuously by specific inhibitors of ferroptosis such as ferrostatin-1 and liproxstatin-1. However, the decrease in Complex I activity upon rotenone-treatment of SH-SY5Y cells is not significantly recovered by ferrostatin-1 and liproxstatin-1. When the rotenone-treated cells are analyzed morphologically by Hoechst 33258 and propidium iodide (PI) staining, a mixed picture is noticed with densely fluorescent and condensed nuclei indicating apoptotic death of cells (Hoechst 33258) and also significant numbers of necrotic cells with bright red nuclei (PI staining).<br> | |||
|keywords=rotenone, mitochondria, ferroptosis, reactive oxygen species, neurodegeneration | |keywords=rotenone, mitochondria, ferroptosis, reactive oxygen species, neurodegeneration | ||
|mipnetlab=IN Haldia Chakrabarti S | |mipnetlab=IN Haldia Chakrabarti S | ||
Line 13: | Line 13: | ||
== Affiliations and support == | == Affiliations and support == | ||
::::Ganguly U | :::: Ganguly U<sup>1</sup>, Bir A<sup>2</sup>, Chakrabarti S<sup>1</sup> | ||
::::#Department of Biochemistry and Central Research Laboratory, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar University (Deemed to be), Mullana, Ambala, India - [email protected] | ::::# Department of Biochemistry and Central Research Laboratory, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar University (Deemed to be), Mullana, Ambala, India - [email protected] | ||
::::#Department of Biochemistry, Dr. B.C. Roy Multispeciality Medical Research Centre, IIT Kharagpur, India | ::::# Department of Biochemistry, Dr. B.C. Roy Multispeciality Medical Research Centre, IIT Kharagpur, India | ||
== List of abbreviations, terms and definitions - MitoPedia == | |||
{{Template:List of abbreviations, terms and definitions - MitoPedia}} | |||
{{Labeling | {{Labeling | ||
|diseases=Parkinson's | |diseases=Parkinson's | ||
Line 26: | Line 26: | ||
|enzymes=Complex I, Complex III | |enzymes=Complex I, Complex III | ||
|topics=ATP production, Inhibitor, mt-Membrane potential | |topics=ATP production, Inhibitor, mt-Membrane potential | ||
|articletype=Abstract | |articletype=Abstract | ||
}} | }} |
Latest revision as of 16:23, 20 June 2022
Not presented Ganguly U, Bir A, Chakrabarti Sasanka (2022) Cytotoxicity of mitochondrial Complex I inhibitor rotenone: a complex interplay of cell death pathways. Bioblast 2022: BEC Inaugural Conference. In: https://doi.org/10.26124/bec:2022-0001 »MitoFit Preprint« |
Link: Bioblast 2022: BEC Inaugural Conference
Ganguly Upasana, Bir Aritri, Chakrabarti Sasanka (2022)
Event:
Ferroptosis has been identified as a type of regulated cell death triggered by a diverse set of agents with implications in various diseases like cancer and neurodegenerative diseases. Ferroptosis is iron-dependent and accompanied by an accumulation of reactive oxygen species (ROS) and lipid oxidation products, a depletion of reduced glutathione, mitochondrial morphological alterations and the rupture of cell membrane; the process is inhibited by specific antioxidants like ferrostatin-1 and liproxstatin-1 and by other general antioxidants like the iron-chelator deferoxamine, vitamin E and N-acetylcysteine. However, the mechanism of cell death in ferroptosis subsequent to the accumulation of ROS and lipid oxidation products is not clearly established. We show here that the classical mitochondrial Complex I inhibitor rotenone (0.5 µM) causes death of SH-SY5Y cells (a human neuroblastoma cell line) over a period of 48 h accompanied by mitochondrial membrane depolarization and intracellular ATP depletion. This is associated with an intracellular accumulation of ROS and the lipid oxidation product malondialdehyde or MDA and a decrease in reduced glutathione content. All these processes are inhibited very conspicuously by specific inhibitors of ferroptosis such as ferrostatin-1 and liproxstatin-1. However, the decrease in Complex I activity upon rotenone-treatment of SH-SY5Y cells is not significantly recovered by ferrostatin-1 and liproxstatin-1. When the rotenone-treated cells are analyzed morphologically by Hoechst 33258 and propidium iodide (PI) staining, a mixed picture is noticed with densely fluorescent and condensed nuclei indicating apoptotic death of cells (Hoechst 33258) and also significant numbers of necrotic cells with bright red nuclei (PI staining).
• Keywords: rotenone, mitochondria, ferroptosis, reactive oxygen species, neurodegeneration
• O2k-Network Lab: IN Haldia Chakrabarti S
Affiliations and support
- Ganguly U1, Bir A2, Chakrabarti S1
- Department of Biochemistry and Central Research Laboratory, Maharishi Markandeshwar Institute of Medical Sciences and Research, Maharishi Markandeshwar University (Deemed to be), Mullana, Ambala, India - [email protected]
- Department of Biochemistry, Dr. B.C. Roy Multispeciality Medical Research Centre, IIT Kharagpur, India
- Ganguly U1, Bir A2, Chakrabarti S1
List of abbreviations, terms and definitions - MitoPedia
Labels:
Pathology: Parkinson's
Stress:Cell death, Oxidative stress;RONS
Tissue;cell: Nervous system, Neuroblastoma
Enzyme: Complex I, Complex III Regulation: ATP production, Inhibitor, mt-Membrane potential